152 related articles for article (PubMed ID: 22940623)
1. Innovation in surfactant therapy II: surfactant administration by aerosolization.
Pillow JJ; Minocchieri S
Neonatology; 2012; 101(4):337-44. PubMed ID: 22940623
[TBL] [Abstract][Full Text] [Related]
2. Innovation in surfactant therapy I: surfactant lavage and surfactant administration by fluid bolus using minimally invasive techniques.
Dargaville PA
Neonatology; 2012; 101(4):326-36. PubMed ID: 22940622
[TBL] [Abstract][Full Text] [Related]
3. Aerosolized surfactants.
Mazela J; Merritt TA; Finer NN
Curr Opin Pediatr; 2007 Apr; 19(2):155-62. PubMed ID: 17496758
[TBL] [Abstract][Full Text] [Related]
4. A novel continuous powder aerosolizer (CPA) for inhalative administration of highly concentrated recombinant surfactant protein-C (rSP-C) surfactant to preterm neonates.
Pohlmann G; Iwatschenko P; Koch W; Windt H; Rast M; de Abreu MG; Taut FJ; De Muynck C
J Aerosol Med Pulm Drug Deliv; 2013 Dec; 26(6):370-9. PubMed ID: 23421901
[TBL] [Abstract][Full Text] [Related]
5. Aerosolized medications for altering lung surface active properties.
MacIntyre NR
Respir Care; 2000 Jun; 45(6):676-83. PubMed ID: 10894460
[TBL] [Abstract][Full Text] [Related]
6. Ultrasonic nebulized in comparison with instilled surfactant treatment of preterm lambs.
Henry MD; Rebello CM; Ikegami M; Jobe AH; Langenback EG; Davis JM
Am J Respir Crit Care Med; 1996 Aug; 154(2 Pt 1):366-75. PubMed ID: 8756808
[TBL] [Abstract][Full Text] [Related]
7. Minimally Invasive Surfactant Therapy and Noninvasive Respiratory Support.
Kribs A
Clin Perinatol; 2016 Dec; 43(4):755-771. PubMed ID: 27837757
[TBL] [Abstract][Full Text] [Related]
8. Surfactant and the neonatal lung.
Gibson AT
Br J Hosp Med; 1997 Oct 15-Nov 4; 58(8):381-4, 397. PubMed ID: 9509038
[TBL] [Abstract][Full Text] [Related]
9. Minimally invasive approaches for surfactant administration.
Trevisanuto D; Marchetto L
Acta Biomed; 2013; 84 Suppl 1():28-31. PubMed ID: 24049959
[TBL] [Abstract][Full Text] [Related]
10. Respiratory distress syndrome--new therapeutic approaches to a complex pathophysiology.
Jobe A
Adv Pediatr; 1983; 30():93-130. PubMed ID: 6369946
[TBL] [Abstract][Full Text] [Related]
11. Nebulization of Poractant alfa via a vibrating membrane nebulizer in spontaneously breathing preterm lambs with binasal continuous positive pressure ventilation.
Hütten MC; Kuypers E; Ophelders DR; Nikiforou M; Jellema RK; Niemarkt HJ; Fuchs C; Tservistas M; Razetti R; Bianco F; Kramer BW
Pediatr Res; 2015 Dec; 78(6):664-9. PubMed ID: 26322413
[TBL] [Abstract][Full Text] [Related]
12. Aerosolized surfactant in neonatal respiratory distress syndrome: Phase I study.
Sood BG; Cortez J; Kolli M; Sharma A; Delaney-Black V; Chen X
Early Hum Dev; 2019 Jul; 134():19-25. PubMed ID: 31121339
[TBL] [Abstract][Full Text] [Related]
13. Recent clinical trials of surfactant treatment for neonates.
Halliday HL
Biol Neonate; 2006; 89(4):323-9. PubMed ID: 16770072
[TBL] [Abstract][Full Text] [Related]
14. Surfactant for respiratory distress syndrome: are there important clinical differences among preparations?
Sinha S; Moya F; Donn SM
Curr Opin Pediatr; 2007 Apr; 19(2):150-4. PubMed ID: 17496757
[TBL] [Abstract][Full Text] [Related]
15. A comparison of surfactant as immediate prophylaxis and as rescue therapy in newborns of less than 30 weeks' gestation.
Kendig JW; Notter RH; Cox C; Reubens LJ; Davis JM; Maniscalco WM; Sinkin RA; Bartoletti A; Dweck HS; Horgan MJ
N Engl J Med; 1991 Mar; 324(13):865-71. PubMed ID: 2000109
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms to explain surfactant responses.
Jobe AH
Biol Neonate; 2006; 89(4):298-302. PubMed ID: 16770069
[TBL] [Abstract][Full Text] [Related]
17. [Drug treatments of respiratory distress syndrome in premature infants].
Saliba E; Laugier J
Pediatrie; 1993; 48(12):864-71. PubMed ID: 8047397
[TBL] [Abstract][Full Text] [Related]
18. Management of respiratory distress syndrome: an update.
Rodriguez RJ
Respir Care; 2003 Mar; 48(3):279-86; discussion 286-7. PubMed ID: 12667277
[TBL] [Abstract][Full Text] [Related]
19. Aerosolized Calfactant for Newborns With Respiratory Distress: A Randomized Trial.
Cummings JJ; Gerday E; Minton S; Katheria A; Albert G; Flores-Torres J; Famuyide M; Lampland A; Guthrie S; Kuehn D; Weitkamp JH; Fort P; Abu Jawdeh EG; Ryan RM; Martin GC; Swanson JR; Mulrooney N; Eyal F; Gerstmann D; Kumar P; Wilding GE; Egan EA;
Pediatrics; 2020 Nov; 146(5):. PubMed ID: 33060258
[TBL] [Abstract][Full Text] [Related]
20. Use of surfactant in the prevention and treatment of neonatal respiratory distress syndrome.
Reynolds MS; Wallander KA
Clin Pharm; 1989 Aug; 8(8):559-76. PubMed ID: 2670398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
